Long COVID in the spotlight: Stakeholders look toward care, treatments and prevention
By
Alicia Lasek
Oct 31, 2022
A picture of numerous, long-lasting symptoms and public health burden has emerged, spurring healthcare stakeholders to take new action in support of clinicians, patients and systems.
Clinical briefs for Tuesday, May 3
By
Alicia Lasek (f3)
May 03, 2022
Paxlovid does not prevent COVID-19, new trial data show … Black and white patients have had similar risk of MS for decades, study finds … Parkinson’s drug hopeful found safe in early clinical trial...
Diabetes deaths reach 100,000 second year in a row, sparking calls for federal action
By
Alicia Lasek
Feb 01, 2022
The news is cause for alarm, experts say. A congressional commission is calling for broad federal policy changes to tackle the swiftly growing problem.
FDA OKs first injectable antibody drug to prevent COVID-19 in high-risk patients
By
Alicia Lasek
Dec 10, 2021
One dose of injectable Evusheld may be effective for 6 months, FDA says. The drug neutralizes all previous SARS-CoV-2 variants, and AstraZeneca says it is working to establish its efficacy against the...
Poorly controlled diabetes — not diabetes itself — triples dementia risk, study finds
By
Alicia Lasek
Oct 13, 2021
In the absence of a cure for dementia, prevention is vital, and a new study offers evidence that this can be done through the careful control of diabetes, investigators say.
Elders get a cognitive boost after positive social interactions, mobile study finds
By
Alicia Lasek
Sep 15, 2021
In a smartphone-enabled study, adults aged 70 years and older had better cognitive performance the same day that they reported having more frequent, pleasant social interactions than usual — and on the...
Pfizer, Merck start testing COVID prevention pills in late-stage trials
By
Alicia Lasek
Sep 02, 2021
The drugs, each given orally as a pill, would provide an unprecedented COVID-19 preventive medication option if brought to market.
Antibody shot cuts COVID-19 infection risk by 66 percent after exposure, drugmaker says
By
Alicia Lasek
Aug 09, 2021
Regeneron’s REGEN-COV antibody cocktail significantly reduces the relative risk of infection after exposure to a close contact infected with SARS-CoV-2, new data show. Symptomatic illness is also shorter...
Moderna’s COVID vaccine tops 90% efficacy, can be refrigerated for 1 month
By
Alicia Lasek
Nov 17, 2020
Moderna’s trial vaccine will have big distribution advantages over Pfizer’s similarly successful candidate if both drugs are approved by the FDA.
Regaining an appreciation of prevention
By
Tara Roberts
Feb 05, 2015
Healthcare is mandated to reduce spending. The problem is that the Centers for Medicare & Medicaid Services and others are so blinded by the “reduce spending” element that we have lost our...